RU2354647C2 - Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе - Google Patents

Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе Download PDF

Info

Publication number
RU2354647C2
RU2354647C2 RU2007124201/04A RU2007124201A RU2354647C2 RU 2354647 C2 RU2354647 C2 RU 2354647C2 RU 2007124201/04 A RU2007124201/04 A RU 2007124201/04A RU 2007124201 A RU2007124201 A RU 2007124201A RU 2354647 C2 RU2354647 C2 RU 2354647C2
Authority
RU
Russia
Prior art keywords
alkyl
hydrogen
group
pharmaceutically acceptable
alkoxy
Prior art date
Application number
RU2007124201/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2007124201A (ru
Inventor
Елена Ивановна Синауридзе (RU)
Елена Ивановна Синауридзе
Фазоил Иноятович Атауллаханов (RU)
Фазоил Иноятович Атауллаханов
Андрей Александрович Бутылин (RU)
Андрей Александрович Бутылин
Владимир Борисович Сулимов (RU)
Владимир Борисович Сулимов
Алексей Николаевич Романов (RU)
Алексей Николаевич Романов
Алексей Алексеевич Боголюбов (RU)
Алексей Алексеевич Боголюбов
Юрий Владимирович Кузнецов (RU)
Юрий Владимирович Кузнецов
Ирина Владимировна Грибкова (RU)
Ирина Владимировна Грибкова
Александр Сергеевич Горбатенко (RU)
Александр Сергеевич Горбатенко
Ольга Анатольевна Кондакова (RU)
Ольга Анатольевна Кондакова
Original Assignee
Общество С Ограниченной Ответственностью "Бионика"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RU2007124201/04A priority Critical patent/RU2354647C2/ru
Application filed by Общество С Ограниченной Ответственностью "Бионика" filed Critical Общество С Ограниченной Ответственностью "Бионика"
Priority to EP08794028A priority patent/EP2178838A2/en
Priority to CA2693226A priority patent/CA2693226A1/en
Priority to US12/666,221 priority patent/US20100324058A1/en
Priority to PCT/RU2008/000400 priority patent/WO2009002228A2/en
Priority to KR1020107002057A priority patent/KR20100039867A/ko
Priority to JP2010514671A priority patent/JP2010531352A/ja
Priority to AU2008269712A priority patent/AU2008269712B2/en
Priority to UAA201000792A priority patent/UA98970C2/ru
Priority to CN200880104825A priority patent/CN101861304A/zh
Priority to EA201000063A priority patent/EA201000063A1/ru
Publication of RU2007124201A publication Critical patent/RU2007124201A/ru
Application granted granted Critical
Publication of RU2354647C2 publication Critical patent/RU2354647C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
RU2007124201/04A 2007-06-28 2007-06-28 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе RU2354647C2 (ru)

Priority Applications (11)

Application Number Priority Date Filing Date Title
RU2007124201/04A RU2354647C2 (ru) 2007-06-28 2007-06-28 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
CA2693226A CA2693226A1 (en) 2007-06-28 2008-06-27 New compounds with antithrombin function and pharmaceutical compositions on their basis
US12/666,221 US20100324058A1 (en) 2007-06-28 2008-06-27 thrombin function compounds and pharmaceutical compositions based on them
PCT/RU2008/000400 WO2009002228A2 (en) 2007-06-28 2008-06-27 New thrombin function compounds and pharmaceutical compositions based on them
EP08794028A EP2178838A2 (en) 2007-06-28 2008-06-27 New thrombin function compounds and pharmaceutical compositions based on them
KR1020107002057A KR20100039867A (ko) 2007-06-28 2008-06-27 신규한 트롬빈 작용 화합물 및 이들을 기초로 한 약제 조성물
JP2010514671A JP2010531352A (ja) 2007-06-28 2008-06-27 新規トロンビン機能性化合物およびそれらに基づいた医薬組成物
AU2008269712A AU2008269712B2 (en) 2007-06-28 2008-06-27 New antithrombin function compounds and pharmaceutical compositions based on them
UAA201000792A UA98970C2 (ru) 2007-06-28 2008-06-27 Соединения с функцией ингибирования тромбина и фармацевтические композиции на их основе
CN200880104825A CN101861304A (zh) 2007-06-28 2008-06-27 新的凝血酶功能化合物和基于其的药物组合物
EA201000063A EA201000063A1 (ru) 2007-06-28 2008-06-27 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007124201/04A RU2354647C2 (ru) 2007-06-28 2007-06-28 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе

Publications (2)

Publication Number Publication Date
RU2007124201A RU2007124201A (ru) 2009-01-10
RU2354647C2 true RU2354647C2 (ru) 2009-05-10

Family

ID=40186195

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007124201/04A RU2354647C2 (ru) 2007-06-28 2007-06-28 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе

Country Status (11)

Country Link
US (1) US20100324058A1 (enExample)
EP (1) EP2178838A2 (enExample)
JP (1) JP2010531352A (enExample)
KR (1) KR20100039867A (enExample)
CN (1) CN101861304A (enExample)
AU (1) AU2008269712B2 (enExample)
CA (1) CA2693226A1 (enExample)
EA (1) EA201000063A1 (enExample)
RU (1) RU2354647C2 (enExample)
UA (1) UA98970C2 (enExample)
WO (1) WO2009002228A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2685261C1 (ru) * 2018-04-05 2019-04-17 Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" Вещество 4-амино-1-{ 2-[3-метил-5-(бензолсульфонилокси)фенокси] этил} -пиридиний хлорид, обладающее свойствами биологически активного агента, влияющими на естественно текущие процессы свертываемости крови млекопитающих, антикоагулянт на его основе и способ его получения путем химического синтеза

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2353619C2 (ru) * 2007-06-28 2009-04-27 Общество С Ограниченной Ответственностью "Бионика" Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции
WO2013048787A1 (en) 2011-09-26 2013-04-04 Yes, Inc. Novel hemostatic compositions and dressings for bleeding
WO2013056116A1 (en) * 2011-10-12 2013-04-18 The Trustees Of Columbia University In The City Of New York Hemostatic dressing for arterial bleeding
FR3030516B1 (fr) * 2014-12-19 2019-12-27 Galderma Research & Development Derives sulfonamides bicycles en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
US5792799A (en) * 1996-10-10 1998-08-11 Athena Neurosciences, Inc. Parenteral delivery of MAO A inhibitors
RU2126388C1 (ru) * 1993-03-03 1999-02-20 Берингер Маннхайм ГмбХ 4-аминопиридины и фармацевтическая композиция

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1469906A (en) 1921-08-26 1923-10-09 Augie L Hansen Tufting needle
DE1245937B (enExample) * 1964-09-09 1967-08-03
US5089634A (en) * 1984-08-20 1992-02-18 Georgia Tech Research Corporation Isocoumarins with cationic substituents
US5214052A (en) 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
JPH0341065A (ja) * 1989-07-06 1991-02-21 Morishita Pharmaceut Co Ltd アリールオキシアルキルイソチオウレア臭化水素酸塩類
JP3084458B2 (ja) * 1991-11-08 2000-09-04 コニカ株式会社 ハロゲン化銀写真感光材料
IL109319A0 (en) * 1993-04-27 1994-07-31 Du Pont Merck Pharma Amidino and guanidino substituted boronic acid compounds
DE4430757A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue 4-Aminopyridazine, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
SE9404196D0 (sv) 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
US5792769A (en) * 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
EP0906091B1 (en) * 1996-03-29 2006-10-04 Ortho-McNeil Pharmaceuticals, Inc. Amidinohydrazones as protease inhibitors
EP0927035A4 (en) * 1996-09-13 2002-11-13 Merck & Co Inc THROMBIN INHIBITORS
US5792779A (en) 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
JP4896387B2 (ja) * 2003-09-30 2012-03-14 武田薬品工業株式会社 チアゾリン誘導体およびその用途
CA2557719A1 (en) * 2004-03-02 2005-10-13 F. Hoffmann-La Roche Ag 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
RU2008152788A (ru) * 2006-05-31 2010-07-10 Эбботт Лэборетриз (Us) Новые соединения в качестве лигандов каннабиноидных рецепторов и их применение
RU2353619C2 (ru) * 2007-06-28 2009-04-27 Общество С Ограниченной Ответственностью "Бионика" Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126388C1 (ru) * 1993-03-03 1999-02-20 Берингер Маннхайм ГмбХ 4-аминопиридины и фармацевтическая композиция
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
US5792799A (en) * 1996-10-10 1998-08-11 Athena Neurosciences, Inc. Parenteral delivery of MAO A inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2685261C1 (ru) * 2018-04-05 2019-04-17 Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" Вещество 4-амино-1-{ 2-[3-метил-5-(бензолсульфонилокси)фенокси] этил} -пиридиний хлорид, обладающее свойствами биологически активного агента, влияющими на естественно текущие процессы свертываемости крови млекопитающих, антикоагулянт на его основе и способ его получения путем химического синтеза

Also Published As

Publication number Publication date
EP2178838A2 (en) 2010-04-28
CA2693226A1 (en) 2008-12-31
CN101861304A (zh) 2010-10-13
WO2009002228A2 (en) 2008-12-31
UA98970C2 (ru) 2012-07-10
AU2008269712A8 (en) 2010-04-15
RU2007124201A (ru) 2009-01-10
JP2010531352A (ja) 2010-09-24
AU2008269712B2 (en) 2013-01-17
KR20100039867A (ko) 2010-04-16
EA201000063A1 (ru) 2010-06-30
WO2009002228A3 (en) 2009-03-12
US20100324058A1 (en) 2010-12-23
AU2008269712A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
RU2354647C2 (ru) Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
EA200970461A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
NO20091591L (no) Hepatitt C virusinhibitorer
NO20091704L (no) Inhibitorer av hepatitt C virus
NO20091707L (no) Inhibitorer av hepatitt C virus
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
NO20062267L (no) Hepatitt C virus inhibitorer
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
NO20062339L (no) Hepatitt C virus-inhibitoerer
EA200600358A1 (ru) Фенил- или пиридиламидные соединения в качестве антагонистов простагландина е2
NO20082934L (no) Antivirale nukleotider
RU2010107684A (ru) Конденсированные гетероциклы
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
EA201170384A1 (ru) Пиррольные соединения
NO20090856L (no) STAT3/5 activeringsinhibitor
JP2013531029A5 (enExample)
HRP20020175B1 (hr) N-heterociklički derivati kao inhibitori nos
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
NO20044807L (no) Heratitt C virus inhibitorer
ATE329565T1 (de) Haarbehandlungsmittel und haarnachbehandlungsmittel zum schutz vor schäden durch chemische behandlung und zur reparatur bereits geschädigter haare enthaltend als wirksubstanz alkylguanidin-verbindungen
NZ605010A (en) Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory agents
MX2011007864A (es) Isosteros para realzar la transcripcion y su uso en terapia.

Legal Events

Date Code Title Description
PC4A Invention patent assignment

Effective date: 20091002

PD4A Correction of name of patent owner
PC4A Invention patent assignment

Effective date: 20100310

MM4A The patent is invalid due to non-payment of fees

Effective date: 20130629

NF4A Reinstatement of patent

Effective date: 20151120

PC41 Official registration of the transfer of exclusive right

Effective date: 20160113

MM4A The patent is invalid due to non-payment of fees

Effective date: 20180629